SlideShare ist ein Scribd-Unternehmen logo
1 von 10
Gastrointestinal Disease
Case
A 38 year old woman presents to the office with complaints of upper abdominal pain. She describes
pain as intermittent gnawing discomfort, often worse after meals. She denies any change in bowel
habits, dark stool or blood in the stool. She has not had any weight loss.
• What is your differential diagnosis?
• What other features of the history and physical exam would you focus on?
The patient reports none of the “alarm” symptoms on history. On exam she has some mild
midepigastric tenderness, no palpable masses. Rectal exam is normal, stool is negative for occult
blood.
• How would you proceed with your work-up?
• Should she have an endoscopy?
• Should she be tested for H. Pylori?
Her H. Pylori serology is positive. You opt to treat empirically.
• What regimen would you use?
The patient completes her treatment and 1 month later reports that her symptoms have completely
resolved. The following year she comes in for her annual exam and mentions that she is having
frequent “heartburn”
• What lifestyle modifications would you recommend?
• How would you treat her?
• Does she need an endoscopy?
America’s OB/GYN Board Review Course™ Miller
April 2013 97
Gastrointestinal Disease
Dyspepsia
Definitions
• Dyspepsia refers to pain or discomfort centered in the upper abdomen (mainly in
or around the midline as opposed to the right or left hypochondrium).
• Functional dyspepsia (normal dyspepsia)- normal endoscopy
• Structural dyspepsia – abnormal endoscopy
 Peptic ulcer disease (duodenal and peptic ulcer)
 Gastritis
 Esophagitis
 Gastric carcinoma
Functional dyspepsia (60%)
• Defined as 3 month h/o dyspepsia with no structural or biochemical explanation
• Etiology unclear
• Associated with GI dysmotility, altered visceral sensation, psychiatric d/o
• Most common form of dyspepsia
• Treatment controversial
• A number of medications have been tried (H2 blockers, prokinetic agents, PPI)
• Patient education, validation important
Peptic Ulcer Disease (15-25%)
• Pain occurs 2-5 hours after eating
• Pain described as gnawing, burning
• Most often localized to the epigastrum, may radiate to back
• Usually episodic
• Frequently nocturnal
• Relieved by food
• 95% duodenal ulcers, 70% of gastric ulcers caused by H. Pylori
• 70% of gastric ulcer caused by H. Pylori
Gastritis
• The term gastritis is used to denote inflammation associated with mucosal injury
• Most often caused by drugs (NSAIDs, alcohol) or Helicobacter pylori
Alarm symptoms: (Don’t want to miss gastric carcinoma!)
• Age > 55 with new-onset dyspepsia
• Unintended weight loss
• GI Bleeding
• Progressive dysphagia
• Odynophagia
• Unexplained iron deficiency anemia
• Persistent vomiting
• Palpable mass or lymphadenopathy
America’s OB/GYN Board Review Course™ Miller
April 2013 98
• Family h/o UGI carcinoma
• Jaundice
H. Pylori
• In U.S. H. Pylori present in 10% of 18-30 yo, 50% in > 60 yo
• More common in black and Hispanic population and lower socioeconomic groups
• Transmission is oral-oral or fecal-oral
• Disrupts protective mucosal layer resulting in cell injury
• Diagnosis
o Blood test for specific antibodies
o Urea breath test
o Stool tests
o Endoscopy with tissue examination/culture
Treatment Regimens for H.Pylori
America’s OB/GYN Board Review Course™ Miller
April 2013 99
Gastoresophageal reflux disease (GERD)
 Clinical symptoms include heartburn, regurgitation and dysphagia
 May mimic angina pectoris
 Can lead to esophagitis
 Complications may include reflux-induced asthma, laryngitis, cough
 Less commonly may lead to Barrett’s esophagus, stricture, cancer
 Treatment
o Lifestyle modification
• Small frequent meals
• Elevate head of bed
• Avoid alcohol, caffeine, smoking, caffeine
• Avoid citrus, tomato foods, chocolate, mints, fatty foods
• Weight management
o Medications
• Over-the-counter antacids
• H2 Blockers (Ranitidine 150 mg BID)
• Proton pump inhibitors
Indications for endoscopy for GERD
• Failure of empiric therapy
• Alarm symptoms
o Over 50 yo with new onset sxs
o GI Bleeding
America’s OB/GYN Board Review Course™ Miller
April 2013 100
REGIMEN SIDE EFFECT CURE RATE
2- Drug Regimens
Amoxicillin + PPI Low-medium <70-80%
Clarithromycin +PPI Low-medium >70-90%
3-Drug Regimens
Clarithromycin + metronidazole + PPI Medium >80-90%
Clarithromycin + Amoxicillin + PPI Low-medium >80-90%
Amoxicillin + Metronidazole + PPI Medium >80-90%
Tetracycline + Metronidazole + Sulcrafate Medium >80-90%
4-Drug Regimens
Bismuth + Metronidazole + Tetracycline+ H2 Blocker Medium-high >80-90%
Bismuth + Metronidazole + Amoxicillin + PPI Medium-high >70-90%
Bismuth + Metronidazole + Tetracycline +PPI Medium-high >80-90%
Bismuth + Metronidazole + Clarithromycin + PPI Medium-high >80-90%
Combination Products
Helidac (Bismuth, metronidazole, tetracycline) + H2
blocker
Medium-high Up to 82%
Prevpac (Amoxiciliin, Clarithromycin,PPI) Low-medium 81-92%
Pylera (Bismuth, metronidazole, tetracyline Low-medium 84-94%
o Unintended Weight loss
o Anemia
o Dysphagia/odynophagia
o Long duration of frequent symptoms
Diarrhea
Acute < 14 days Most due to infectious and are self-
limited
Persistent >14 days
Chronic >30 days IBS, IBD, malabsorption, secretory
America’s OB/GYN Board Review Course™ Miller
April 2013 101
Evaluation of Acute Diarrhea
Irritable Bowel Syndrome
• Female to male ratio of 2-3 :1
• Most common between ages of 20-40
Clinical Manifestations
• Crampy abdominal pain for > 3 months, usually lower quadrants, often on the left
America’s OB/GYN Board Review Course™ Miller
April 2013 102
Specific Therapy for Diarrhea
• Altered bowel habits – diarrhea and/or constipation
• May have bloating, nausea, dyspepsia, early satiety, increased flatulence or
belching
• Patients with IBS often complain of a broad range of non-gastrointestinal
symptoms including impaired sexual function, dysmenorrhea, dyspareunia, and
increased urinary frequency and urgency.
Work-up for IBS
1. Careful history and physical (exam should be normal)
2. Rule out dietary causes and/or medications (lactose , mg –containing antacids
cause diarrhea, anticholinergics, ca-channel blockers can cause constipation)
3. Look for other underlying etiologies such as depression, anxiety, physical, sexual
or substance abuse
4. Look for alarm symptoms
a. > 50 yo with new sxs
b. GI bleeding
c. Unintended weight loss
d. Family history of colon cancer
e. Recurring fever
f. Anemia
g. Chronic severe diarrhea.
5. Lab evaluation should include CBC, chemistries, and stool for WBC, Cx, O&P, c.
diff (to r/o infectious etiology)
6. Recommend flex sig/colonoscopy for patients with any alarm symptoms or for
persistent symptoms
Treatment of IBS
• Cure is not expected, but symptoms can be modified
• Most important element is reassuring, therapeutic patient-physician relationship
• Therapy should include
o Avoidance of foods the increase symptoms
o High fiber diet (25-35 gm fiber/day)
o Medication efficacy has not been established in RCTs
o Trial of medications may be warranted
• Antidiarrheal agents (loperamide, diphenoxylate)
• Anticholinergics (belladonna, dicylomine, hycosamine) for
pain/gas/bloating
• Tricyclic antidepressants may be helpful in pain-dominant
IBS
• Tegaserod (Zelnorm)
America’s OB/GYN Board Review Course™ Miller
April 2013 103
o Removed from market
o Was for constipation-dominant IBS in women
Inflammatory Bowel Disease
• Incidence peaks in 2nd
and 3rd
decade
• Usually present with recurrent diarrhea and abdominal pain, fever
• Often anemic, may have leukocytosis, thrombocytosis
• May have electrolyte abnormalities and elevated ESR
• Diagnostic test = colonoscopy
• Extraintestinal manifestations of IBD include iritis, episcleritis, arthritis, and skin
involvement, as well as pericholangitis and sclerosing cholangitis.
Crohns disease Ulcerative Colitis
Involves all layers of the bowel
Can occur anywhere in GI tract
Lesions discontinuous with skip areas
Most commonly present with nonbloody
diarrhea
May recur after surgery
Involves only mucosa and submucosa
Only involves rectum and lg bowel
Lesions continuous with abrupt
demarcation
Most commonly present with bloody
diarrhea
Surgery usually curative
Medications for IBD
• Aminosalicylates (sulfasalazine, mesalamine) – used for maintenance therapy
• Steroids – used for acute attacks
• Immunosuppressants (Azathioprine) – useful for patients unable to tolerate
steroids
• Tumor Necrosis Inhibitors (Inflixamab) – used to induce remission in patients
unresponsive to other treatments
Complications of IBD
• Perforation, toxic megacolon (UC > Crohns)
• Strictures
• Fistulas and Abcesses (Crohns > UC)
• Colon cancer – risk increases with extent and duration of disease
Screening for Colon Cancer
Risk factor Age to initiate screening Interval of screening
Average risk 50 years
45 years for African American
FOBT yearly
Sigmoidoscopy q 5 yrs
Colonoscopy q 10 yrs
Family history Screen as average risk Interval as in average risk
America’s OB/GYN Board Review Course™ Miller
April 2013 104
1 second degree or third degree
relative
Family history
1 first degree or 2 second degree
relatives > 60 yrs
40 years Colonoscopy q 5-10 years
Family history
1 first degree or 2 second degree
relatives < 60 yrs
40 years or 10 years prior to the
index case, whichever comes first
Colonoscopy q 5-10 years
Familial adenomatous polyposis
(FAP)
10-12 years Yearly sigmoidoscopy. If genetic
test positive, colectomy
recommended
Hereditary nonpolyposis
colorectal cancer (HNPCC)
20-25 years or 10 years prior to
the youngest dx of colon cancer
in the family
Colonoscopy q 1-2 years
Inflammatory bowel disease Begin screening after 8-10 years
of disease
Yearly colonoscopy
Oral Defense Tips
 I refer patients with dyspepsia for endoscopy if they have any “alarm symptoms”
(weight loss, blood in stool, unexplained anemia) or they are using chronic
NSAIDs
 My initial treatment for dyspepsia is to do blood testing for H. Pylori and treat if
positive (Prevpac as directed)
 I would counsel a woman with GERD symptoms to have small frequent meals,
elevate the head of the bed, avoid alcohol, caffeine, smoking, caffeine, avoid
citrus, tomato foods, chocolate, mints, fatty foods, and control weight.
 My initial approach to the assessment of diarrhea is to determine duration of
symptoms, and look for signs of dehydration or inflammation (blood, fever). If
the sxs are less than 48 hours, there is no fever or blood in the stool and no signs
of dehydration, I recommend fluid, rest and bland diet.
 My initial approach to the treatment of IBS is to recommend a high fiber diet (25-
35 gm/day) and I ask the patient to keep a food diary.
 I recommend colon cancer screening to ALL women starting at 50 years old and
to African American women starting at 45 years old.
STUDY QUESTIONS
Yearly screening colonoscopy should be recommended for patients with:
A. Irritable bowel syndrome
America’s OB/GYN Board Review Course™ Miller
April 2013 105
B. Occult blood on rectal exam
C. Familial adenomatous polyposis
D. A first degree family member diagnosed with colon cancer under
the age of 60.
A 32 year old woman returns from a camping trip and develops acute diarrhea.
The most likely organism is:
A. E. Coli
B. V.cholera
C. Campylobacter
D. Giardia
Updated 02/13
America’s OB/GYN Board Review Course™ Miller
April 2013 106

Weitere ähnliche Inhalte

Was ist angesagt?

Diabetic gastroparesis
Diabetic gastroparesisDiabetic gastroparesis
Diabetic gastroparesisAli Djumhana
 
Gastroparesis: Causes, Symptoms, Diagnosis and Treatment
Gastroparesis: Causes, Symptoms, Diagnosis and TreatmentGastroparesis: Causes, Symptoms, Diagnosis and Treatment
Gastroparesis: Causes, Symptoms, Diagnosis and TreatmentLazoi Lifecare Private Limited
 
Barrett’s surveillance and early management of ca oesophagus
Barrett’s surveillance and early management of ca oesophagusBarrett’s surveillance and early management of ca oesophagus
Barrett’s surveillance and early management of ca oesophagusElmuhtady Said FRCP FEBGH
 
Gastroparesis case study (2)
Gastroparesis case study (2)Gastroparesis case study (2)
Gastroparesis case study (2)Niccole Couse
 
WWDI Clinical Case Study Presentation-HS
WWDI Clinical Case Study Presentation-HSWWDI Clinical Case Study Presentation-HS
WWDI Clinical Case Study Presentation-HSHillary Sullivan, DTR
 
Enfermería clínica del adulto y adulto mayor.
Enfermería clínica del adulto y adulto mayor.Enfermería clínica del adulto y adulto mayor.
Enfermería clínica del adulto y adulto mayor.KevinDaniel88
 
Recent advances in diabetic gastroparesis
Recent advances in diabetic gastroparesisRecent advances in diabetic gastroparesis
Recent advances in diabetic gastroparesisViraj Shinde
 
Current Trends in Management of Gastroesophageal Reflux Disease
Current Trends in Management of Gastroesophageal Reflux DiseaseCurrent Trends in Management of Gastroesophageal Reflux Disease
Current Trends in Management of Gastroesophageal Reflux DiseaseAadil Sayyed
 
Diabetes SOAP Note Exercise
Diabetes SOAP Note ExerciseDiabetes SOAP Note Exercise
Diabetes SOAP Note ExerciseJoy Awoniyi
 
GERD: Current Paradigms
GERD: Current ParadigmsGERD: Current Paradigms
GERD: Current ParadigmsJarrod Lee
 
Formal case Presentation (care plan for patient has duodenal ulcer caused by...
Formal case Presentation (care plan for  patient has duodenal ulcer caused by...Formal case Presentation (care plan for  patient has duodenal ulcer caused by...
Formal case Presentation (care plan for patient has duodenal ulcer caused by...Aya Ali
 
ULCERATIVE COLITIS ( SEVERE) MANAGEMENT
ULCERATIVE COLITIS ( SEVERE) MANAGEMENT ULCERATIVE COLITIS ( SEVERE) MANAGEMENT
ULCERATIVE COLITIS ( SEVERE) MANAGEMENT Bhavin Mandowara
 
Refractory gerd by prof azis rani
Refractory gerd by prof azis raniRefractory gerd by prof azis rani
Refractory gerd by prof azis raniSuharti Wairagya
 

Was ist angesagt? (20)

Diabetes and GIT
Diabetes and GITDiabetes and GIT
Diabetes and GIT
 
Diabetic gastroparesis
Diabetic gastroparesisDiabetic gastroparesis
Diabetic gastroparesis
 
Post surgical gastroparesis
Post surgical gastroparesisPost surgical gastroparesis
Post surgical gastroparesis
 
Gastroparesis CSGNA 2016
Gastroparesis CSGNA 2016Gastroparesis CSGNA 2016
Gastroparesis CSGNA 2016
 
Gastroparesis: Causes, Symptoms, Diagnosis and Treatment
Gastroparesis: Causes, Symptoms, Diagnosis and TreatmentGastroparesis: Causes, Symptoms, Diagnosis and Treatment
Gastroparesis: Causes, Symptoms, Diagnosis and Treatment
 
Barrett’s surveillance and early management of ca oesophagus
Barrett’s surveillance and early management of ca oesophagusBarrett’s surveillance and early management of ca oesophagus
Barrett’s surveillance and early management of ca oesophagus
 
Gastroparesis case study (2)
Gastroparesis case study (2)Gastroparesis case study (2)
Gastroparesis case study (2)
 
WWDI Clinical Case Study Presentation-HS
WWDI Clinical Case Study Presentation-HSWWDI Clinical Case Study Presentation-HS
WWDI Clinical Case Study Presentation-HS
 
Acid suppression UnAd
Acid suppression UnAdAcid suppression UnAd
Acid suppression UnAd
 
Enfermería clínica del adulto y adulto mayor.
Enfermería clínica del adulto y adulto mayor.Enfermería clínica del adulto y adulto mayor.
Enfermería clínica del adulto y adulto mayor.
 
Ibs update 2020
Ibs update 2020Ibs update 2020
Ibs update 2020
 
Gastroparesis
GastroparesisGastroparesis
Gastroparesis
 
Recent advances in diabetic gastroparesis
Recent advances in diabetic gastroparesisRecent advances in diabetic gastroparesis
Recent advances in diabetic gastroparesis
 
Current Trends in Management of Gastroesophageal Reflux Disease
Current Trends in Management of Gastroesophageal Reflux DiseaseCurrent Trends in Management of Gastroesophageal Reflux Disease
Current Trends in Management of Gastroesophageal Reflux Disease
 
Paediatric Rome iv criteria
Paediatric Rome iv criteriaPaediatric Rome iv criteria
Paediatric Rome iv criteria
 
Diabetes SOAP Note Exercise
Diabetes SOAP Note ExerciseDiabetes SOAP Note Exercise
Diabetes SOAP Note Exercise
 
GERD: Current Paradigms
GERD: Current ParadigmsGERD: Current Paradigms
GERD: Current Paradigms
 
Formal case Presentation (care plan for patient has duodenal ulcer caused by...
Formal case Presentation (care plan for  patient has duodenal ulcer caused by...Formal case Presentation (care plan for  patient has duodenal ulcer caused by...
Formal case Presentation (care plan for patient has duodenal ulcer caused by...
 
ULCERATIVE COLITIS ( SEVERE) MANAGEMENT
ULCERATIVE COLITIS ( SEVERE) MANAGEMENT ULCERATIVE COLITIS ( SEVERE) MANAGEMENT
ULCERATIVE COLITIS ( SEVERE) MANAGEMENT
 
Refractory gerd by prof azis rani
Refractory gerd by prof azis raniRefractory gerd by prof azis rani
Refractory gerd by prof azis rani
 

Andere mochten auch

Andere mochten auch (6)

Path htn pregnancy
Path htn pregnancyPath htn pregnancy
Path htn pregnancy
 
Case radiology: Behcet disease
Case radiology: Behcet diseaseCase radiology: Behcet disease
Case radiology: Behcet disease
 
EITI after 10
EITI after 10EITI after 10
EITI after 10
 
Obgyn exam
Obgyn examObgyn exam
Obgyn exam
 
Obgyn course
Obgyn courseObgyn course
Obgyn course
 
Update in obstetrics and gynecology 2012
Update in obstetrics and gynecology 2012Update in obstetrics and gynecology 2012
Update in obstetrics and gynecology 2012
 

Ähnlich wie 1.12 gi 2013 april

Irritable Bowel Syndrome - Ibs
Irritable Bowel Syndrome - IbsIrritable Bowel Syndrome - Ibs
Irritable Bowel Syndrome - IbsHossam Ghoneim
 
Gastritis and irritable bowel syndrome
Gastritis and irritable bowel syndromeGastritis and irritable bowel syndrome
Gastritis and irritable bowel syndromeShweta Sharma
 
an Approach to Dyspepsia
an Approach to Dyspepsiaan Approach to Dyspepsia
an Approach to DyspepsiaAhmed Almumtin
 
Chronic pancreatitis.pptx
Chronic pancreatitis.pptxChronic pancreatitis.pptx
Chronic pancreatitis.pptxPradeep Pande
 
Non Cardiac Chest Pain
Non Cardiac Chest PainNon Cardiac Chest Pain
Non Cardiac Chest PainJarrod Lee
 
Dyspepsia - Jaber Manasia
Dyspepsia - Jaber ManasiaDyspepsia - Jaber Manasia
Dyspepsia - Jaber ManasiaJaber Manasia
 
Part IV Gasitrointesitinal disorders pharmacotherapy.pptx
Part IV  Gasitrointesitinal disorders pharmacotherapy.pptxPart IV  Gasitrointesitinal disorders pharmacotherapy.pptx
Part IV Gasitrointesitinal disorders pharmacotherapy.pptxAbdiIsaq1
 
peptic ulcer disease.pptx
peptic ulcer disease.pptxpeptic ulcer disease.pptx
peptic ulcer disease.pptxabeerarajput
 
peptic ulcer disease.pptx
peptic ulcer disease.pptxpeptic ulcer disease.pptx
peptic ulcer disease.pptxWebcloud403
 
weight loss and constipation
weight loss and constipationweight loss and constipation
weight loss and constipationmed zar
 
Why Does My Stomach Ache? - Dennis Han, MD, Gastroenterologist - Morristown &...
Why Does My Stomach Ache? - Dennis Han, MD, Gastroenterologist - Morristown &...Why Does My Stomach Ache? - Dennis Han, MD, Gastroenterologist - Morristown &...
Why Does My Stomach Ache? - Dennis Han, MD, Gastroenterologist - Morristown &...Summit Health
 
Non Surg Ac abdomen -Finish.pptx
Non Surg Ac abdomen -Finish.pptxNon Surg Ac abdomen -Finish.pptx
Non Surg Ac abdomen -Finish.pptxNartMood
 
Gastroparesis high yield points
Gastroparesis high yield pointsGastroparesis high yield points
Gastroparesis high yield pointsMusa Abusabha
 
Stomach disorders
Stomach disorders Stomach disorders
Stomach disorders Uma Binoy
 
Acid peptic disease /dental courses /certified fixed orthodontic courses by I...
Acid peptic disease /dental courses /certified fixed orthodontic courses by I...Acid peptic disease /dental courses /certified fixed orthodontic courses by I...
Acid peptic disease /dental courses /certified fixed orthodontic courses by I...Indian dental academy
 

Ähnlich wie 1.12 gi 2013 april (20)

Irritable Bowel Syndrome - Ibs
Irritable Bowel Syndrome - IbsIrritable Bowel Syndrome - Ibs
Irritable Bowel Syndrome - Ibs
 
Gastritis and irritable bowel syndrome
Gastritis and irritable bowel syndromeGastritis and irritable bowel syndrome
Gastritis and irritable bowel syndrome
 
an Approach to Dyspepsia
an Approach to Dyspepsiaan Approach to Dyspepsia
an Approach to Dyspepsia
 
Chronic pancreatitis.pptx
Chronic pancreatitis.pptxChronic pancreatitis.pptx
Chronic pancreatitis.pptx
 
Non Cardiac Chest Pain
Non Cardiac Chest PainNon Cardiac Chest Pain
Non Cardiac Chest Pain
 
Dyspepsia - Jaber Manasia
Dyspepsia - Jaber ManasiaDyspepsia - Jaber Manasia
Dyspepsia - Jaber Manasia
 
Part IV Gasitrointesitinal disorders pharmacotherapy.pptx
Part IV  Gasitrointesitinal disorders pharmacotherapy.pptxPart IV  Gasitrointesitinal disorders pharmacotherapy.pptx
Part IV Gasitrointesitinal disorders pharmacotherapy.pptx
 
peptic ulcer disease.pptx
peptic ulcer disease.pptxpeptic ulcer disease.pptx
peptic ulcer disease.pptx
 
peptic ulcer disease.pptx
peptic ulcer disease.pptxpeptic ulcer disease.pptx
peptic ulcer disease.pptx
 
IBS.pptx
IBS.pptxIBS.pptx
IBS.pptx
 
weight loss and constipation
weight loss and constipationweight loss and constipation
weight loss and constipation
 
Why Does My Stomach Ache? - Dennis Han, MD, Gastroenterologist - Morristown &...
Why Does My Stomach Ache? - Dennis Han, MD, Gastroenterologist - Morristown &...Why Does My Stomach Ache? - Dennis Han, MD, Gastroenterologist - Morristown &...
Why Does My Stomach Ache? - Dennis Han, MD, Gastroenterologist - Morristown &...
 
Non Surg Ac abdomen -Finish.pptx
Non Surg Ac abdomen -Finish.pptxNon Surg Ac abdomen -Finish.pptx
Non Surg Ac abdomen -Finish.pptx
 
Gastroparesis high yield points
Gastroparesis high yield pointsGastroparesis high yield points
Gastroparesis high yield points
 
Presentation
PresentationPresentation
Presentation
 
GERD ppt.pptx
GERD ppt.pptxGERD ppt.pptx
GERD ppt.pptx
 
Peptic ulcer.pptx
Peptic ulcer.pptxPeptic ulcer.pptx
Peptic ulcer.pptx
 
Stomach disorders
Stomach disorders Stomach disorders
Stomach disorders
 
Chronic Diarrhea
Chronic DiarrheaChronic Diarrhea
Chronic Diarrhea
 
Acid peptic disease /dental courses /certified fixed orthodontic courses by I...
Acid peptic disease /dental courses /certified fixed orthodontic courses by I...Acid peptic disease /dental courses /certified fixed orthodontic courses by I...
Acid peptic disease /dental courses /certified fixed orthodontic courses by I...
 

Kürzlich hochgeladen

world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 

Kürzlich hochgeladen (20)

world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 

1.12 gi 2013 april

  • 1. Gastrointestinal Disease Case A 38 year old woman presents to the office with complaints of upper abdominal pain. She describes pain as intermittent gnawing discomfort, often worse after meals. She denies any change in bowel habits, dark stool or blood in the stool. She has not had any weight loss. • What is your differential diagnosis? • What other features of the history and physical exam would you focus on? The patient reports none of the “alarm” symptoms on history. On exam she has some mild midepigastric tenderness, no palpable masses. Rectal exam is normal, stool is negative for occult blood. • How would you proceed with your work-up? • Should she have an endoscopy? • Should she be tested for H. Pylori? Her H. Pylori serology is positive. You opt to treat empirically. • What regimen would you use? The patient completes her treatment and 1 month later reports that her symptoms have completely resolved. The following year she comes in for her annual exam and mentions that she is having frequent “heartburn” • What lifestyle modifications would you recommend? • How would you treat her? • Does she need an endoscopy? America’s OB/GYN Board Review Course™ Miller April 2013 97
  • 2. Gastrointestinal Disease Dyspepsia Definitions • Dyspepsia refers to pain or discomfort centered in the upper abdomen (mainly in or around the midline as opposed to the right or left hypochondrium). • Functional dyspepsia (normal dyspepsia)- normal endoscopy • Structural dyspepsia – abnormal endoscopy  Peptic ulcer disease (duodenal and peptic ulcer)  Gastritis  Esophagitis  Gastric carcinoma Functional dyspepsia (60%) • Defined as 3 month h/o dyspepsia with no structural or biochemical explanation • Etiology unclear • Associated with GI dysmotility, altered visceral sensation, psychiatric d/o • Most common form of dyspepsia • Treatment controversial • A number of medications have been tried (H2 blockers, prokinetic agents, PPI) • Patient education, validation important Peptic Ulcer Disease (15-25%) • Pain occurs 2-5 hours after eating • Pain described as gnawing, burning • Most often localized to the epigastrum, may radiate to back • Usually episodic • Frequently nocturnal • Relieved by food • 95% duodenal ulcers, 70% of gastric ulcers caused by H. Pylori • 70% of gastric ulcer caused by H. Pylori Gastritis • The term gastritis is used to denote inflammation associated with mucosal injury • Most often caused by drugs (NSAIDs, alcohol) or Helicobacter pylori Alarm symptoms: (Don’t want to miss gastric carcinoma!) • Age > 55 with new-onset dyspepsia • Unintended weight loss • GI Bleeding • Progressive dysphagia • Odynophagia • Unexplained iron deficiency anemia • Persistent vomiting • Palpable mass or lymphadenopathy America’s OB/GYN Board Review Course™ Miller April 2013 98
  • 3. • Family h/o UGI carcinoma • Jaundice H. Pylori • In U.S. H. Pylori present in 10% of 18-30 yo, 50% in > 60 yo • More common in black and Hispanic population and lower socioeconomic groups • Transmission is oral-oral or fecal-oral • Disrupts protective mucosal layer resulting in cell injury • Diagnosis o Blood test for specific antibodies o Urea breath test o Stool tests o Endoscopy with tissue examination/culture Treatment Regimens for H.Pylori America’s OB/GYN Board Review Course™ Miller April 2013 99
  • 4. Gastoresophageal reflux disease (GERD)  Clinical symptoms include heartburn, regurgitation and dysphagia  May mimic angina pectoris  Can lead to esophagitis  Complications may include reflux-induced asthma, laryngitis, cough  Less commonly may lead to Barrett’s esophagus, stricture, cancer  Treatment o Lifestyle modification • Small frequent meals • Elevate head of bed • Avoid alcohol, caffeine, smoking, caffeine • Avoid citrus, tomato foods, chocolate, mints, fatty foods • Weight management o Medications • Over-the-counter antacids • H2 Blockers (Ranitidine 150 mg BID) • Proton pump inhibitors Indications for endoscopy for GERD • Failure of empiric therapy • Alarm symptoms o Over 50 yo with new onset sxs o GI Bleeding America’s OB/GYN Board Review Course™ Miller April 2013 100 REGIMEN SIDE EFFECT CURE RATE 2- Drug Regimens Amoxicillin + PPI Low-medium <70-80% Clarithromycin +PPI Low-medium >70-90% 3-Drug Regimens Clarithromycin + metronidazole + PPI Medium >80-90% Clarithromycin + Amoxicillin + PPI Low-medium >80-90% Amoxicillin + Metronidazole + PPI Medium >80-90% Tetracycline + Metronidazole + Sulcrafate Medium >80-90% 4-Drug Regimens Bismuth + Metronidazole + Tetracycline+ H2 Blocker Medium-high >80-90% Bismuth + Metronidazole + Amoxicillin + PPI Medium-high >70-90% Bismuth + Metronidazole + Tetracycline +PPI Medium-high >80-90% Bismuth + Metronidazole + Clarithromycin + PPI Medium-high >80-90% Combination Products Helidac (Bismuth, metronidazole, tetracycline) + H2 blocker Medium-high Up to 82% Prevpac (Amoxiciliin, Clarithromycin,PPI) Low-medium 81-92% Pylera (Bismuth, metronidazole, tetracyline Low-medium 84-94%
  • 5. o Unintended Weight loss o Anemia o Dysphagia/odynophagia o Long duration of frequent symptoms Diarrhea Acute < 14 days Most due to infectious and are self- limited Persistent >14 days Chronic >30 days IBS, IBD, malabsorption, secretory America’s OB/GYN Board Review Course™ Miller April 2013 101 Evaluation of Acute Diarrhea
  • 6. Irritable Bowel Syndrome • Female to male ratio of 2-3 :1 • Most common between ages of 20-40 Clinical Manifestations • Crampy abdominal pain for > 3 months, usually lower quadrants, often on the left America’s OB/GYN Board Review Course™ Miller April 2013 102 Specific Therapy for Diarrhea
  • 7. • Altered bowel habits – diarrhea and/or constipation • May have bloating, nausea, dyspepsia, early satiety, increased flatulence or belching • Patients with IBS often complain of a broad range of non-gastrointestinal symptoms including impaired sexual function, dysmenorrhea, dyspareunia, and increased urinary frequency and urgency. Work-up for IBS 1. Careful history and physical (exam should be normal) 2. Rule out dietary causes and/or medications (lactose , mg –containing antacids cause diarrhea, anticholinergics, ca-channel blockers can cause constipation) 3. Look for other underlying etiologies such as depression, anxiety, physical, sexual or substance abuse 4. Look for alarm symptoms a. > 50 yo with new sxs b. GI bleeding c. Unintended weight loss d. Family history of colon cancer e. Recurring fever f. Anemia g. Chronic severe diarrhea. 5. Lab evaluation should include CBC, chemistries, and stool for WBC, Cx, O&P, c. diff (to r/o infectious etiology) 6. Recommend flex sig/colonoscopy for patients with any alarm symptoms or for persistent symptoms Treatment of IBS • Cure is not expected, but symptoms can be modified • Most important element is reassuring, therapeutic patient-physician relationship • Therapy should include o Avoidance of foods the increase symptoms o High fiber diet (25-35 gm fiber/day) o Medication efficacy has not been established in RCTs o Trial of medications may be warranted • Antidiarrheal agents (loperamide, diphenoxylate) • Anticholinergics (belladonna, dicylomine, hycosamine) for pain/gas/bloating • Tricyclic antidepressants may be helpful in pain-dominant IBS • Tegaserod (Zelnorm) America’s OB/GYN Board Review Course™ Miller April 2013 103
  • 8. o Removed from market o Was for constipation-dominant IBS in women Inflammatory Bowel Disease • Incidence peaks in 2nd and 3rd decade • Usually present with recurrent diarrhea and abdominal pain, fever • Often anemic, may have leukocytosis, thrombocytosis • May have electrolyte abnormalities and elevated ESR • Diagnostic test = colonoscopy • Extraintestinal manifestations of IBD include iritis, episcleritis, arthritis, and skin involvement, as well as pericholangitis and sclerosing cholangitis. Crohns disease Ulcerative Colitis Involves all layers of the bowel Can occur anywhere in GI tract Lesions discontinuous with skip areas Most commonly present with nonbloody diarrhea May recur after surgery Involves only mucosa and submucosa Only involves rectum and lg bowel Lesions continuous with abrupt demarcation Most commonly present with bloody diarrhea Surgery usually curative Medications for IBD • Aminosalicylates (sulfasalazine, mesalamine) – used for maintenance therapy • Steroids – used for acute attacks • Immunosuppressants (Azathioprine) – useful for patients unable to tolerate steroids • Tumor Necrosis Inhibitors (Inflixamab) – used to induce remission in patients unresponsive to other treatments Complications of IBD • Perforation, toxic megacolon (UC > Crohns) • Strictures • Fistulas and Abcesses (Crohns > UC) • Colon cancer – risk increases with extent and duration of disease Screening for Colon Cancer Risk factor Age to initiate screening Interval of screening Average risk 50 years 45 years for African American FOBT yearly Sigmoidoscopy q 5 yrs Colonoscopy q 10 yrs Family history Screen as average risk Interval as in average risk America’s OB/GYN Board Review Course™ Miller April 2013 104
  • 9. 1 second degree or third degree relative Family history 1 first degree or 2 second degree relatives > 60 yrs 40 years Colonoscopy q 5-10 years Family history 1 first degree or 2 second degree relatives < 60 yrs 40 years or 10 years prior to the index case, whichever comes first Colonoscopy q 5-10 years Familial adenomatous polyposis (FAP) 10-12 years Yearly sigmoidoscopy. If genetic test positive, colectomy recommended Hereditary nonpolyposis colorectal cancer (HNPCC) 20-25 years or 10 years prior to the youngest dx of colon cancer in the family Colonoscopy q 1-2 years Inflammatory bowel disease Begin screening after 8-10 years of disease Yearly colonoscopy Oral Defense Tips  I refer patients with dyspepsia for endoscopy if they have any “alarm symptoms” (weight loss, blood in stool, unexplained anemia) or they are using chronic NSAIDs  My initial treatment for dyspepsia is to do blood testing for H. Pylori and treat if positive (Prevpac as directed)  I would counsel a woman with GERD symptoms to have small frequent meals, elevate the head of the bed, avoid alcohol, caffeine, smoking, caffeine, avoid citrus, tomato foods, chocolate, mints, fatty foods, and control weight.  My initial approach to the assessment of diarrhea is to determine duration of symptoms, and look for signs of dehydration or inflammation (blood, fever). If the sxs are less than 48 hours, there is no fever or blood in the stool and no signs of dehydration, I recommend fluid, rest and bland diet.  My initial approach to the treatment of IBS is to recommend a high fiber diet (25- 35 gm/day) and I ask the patient to keep a food diary.  I recommend colon cancer screening to ALL women starting at 50 years old and to African American women starting at 45 years old. STUDY QUESTIONS Yearly screening colonoscopy should be recommended for patients with: A. Irritable bowel syndrome America’s OB/GYN Board Review Course™ Miller April 2013 105
  • 10. B. Occult blood on rectal exam C. Familial adenomatous polyposis D. A first degree family member diagnosed with colon cancer under the age of 60. A 32 year old woman returns from a camping trip and develops acute diarrhea. The most likely organism is: A. E. Coli B. V.cholera C. Campylobacter D. Giardia Updated 02/13 America’s OB/GYN Board Review Course™ Miller April 2013 106